Leukemia: all 5,475 studies
Page 46 of 55. Open to participants first (629), then studies with results posted, then the rest; newest registration first within each.
- Fludarabine, Cytarabine, Topotecan in Treating Patients With Relapsed or Refractory Acute Myeloid LeukemiaCompletedNCT00488709Phase 4
- SMD_FLAG-IDA_98: FLAG-IDA in Induction Treatment of High Risk Myelodysplastic Syndromes or Secondary Acute Myeloblastic LeukemiaCompletedNCT00487448Phase 4
- Study Evaluating Effects of CX-3543 in Patients With Relapsed or Refractory B-Cell Chronic Lymphocytic LeukemiaWithdrawnNCT00485966Phase 2
- Study of Treatment High Risk and/or Low Risk Acute Lymphoblastic leukémia(ALL) Adults Stage IIICompletedNCT00483132Phase 3
- Phase III Trial in Acute Promyelocytic Leukemia PatientsCompletedNCT00482833Phase 3
- Epoetin Alfa or Epoetin Beta With or Without Iron Infusion in Treating Anemia in Patients With CancerStatus unknownNCT00482716Phase 3
- Risk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic LeukemiaCompletedNCT00482352
- Kinetic Biomarker for Chronic Lymphocytic Leukemia PrognosisCompletedNCT00481858
- Lomustine and Intermediate Dose Cytarabine in Older Patients With AMLCompletedNCT00480064Phase 3
- Evaluation of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid LeukemiaCompletedNCT00478985Not applicable
- NOPHO-AML 2004 Study for Children With Acute Myeloid LeukemiaCompletedNCT00476541Phase 3
- High Dose Daunorubicin Vs. Standard Dose Daunorubicin in Induction Treatment of AMLCompletedNCT00474006Phase 3
- Anti-Third Party T Lymphocytes With Nonmyeloablative Stem Cell Transplantation for Indolent Lymphoid MalignanciesTerminatedNCT00473551Phase 1
- Flavopiridol, Cytarabine, and Mitoxantrone in Treating Patients With Relapsed or Refractory Acute LeukemiaCompletedNCT00470197Phase 1
- Vaccine Therapy With or Without Donor Lymphocyte Infusion in Treating Patients With Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia, or Multiple Myeloma Undergoing Donor Stem Cell TransplantTerminatedNCT00469820Phase 1
- Efficacy and Safety Study of StemEx®, to Treat Subjects With High Risk Hematologic Malignancies, Following Myeloablative TherapyCompletedNCT00469729Phase 2/3
- Lenalidomide in Acute Leukemias and Chronic Lymphocytic Leukemia.CompletedNCT00466895Phase 1
- Treatment of Relapsed or Chemotherapy Refractory Chronic Lymphocytic Leukemia or Indolent B Cell Lymphoma Using Autologous T Cells Genetically Targeted to the B Cell Specific Antigen CD19Active, not recruitingNCT00466531Phase 1/2
- Treatment of the Acute Myeloblastic Leukaemia in Patients Over 65 YearsCompletedNCT00464217Phase 4
- Study of XL228 in Subjects With Chronic Myeloid Leukemia or Philadelphia-Chromosome-Positive Acute Lymphocytic LeukemiaTerminatedNCT00464113Phase 1
- Combination Chemotherapy in Treating Young Patients With Relapsed or Refractory Acute LeukemiaCompletedNCT00462787Phase 1
- Early Diagnosis of Aspergillosis in Patients at High Risk of Fungal Infection Caused by Treatment for Hematologic Cancer or Other DiseaseStatus unknownNCT00462657Not applicable
- Safety Study of CAT-8015 Immunooxin in Patients With HCL With Advance DiseaseStatus unknownNCT00462189Phase 1
- Chromosome Abnormalities in Chronic Myeloid Leukemia (CML) on Imatinib. GIST Patients on ImatinibTerminatedNCT00461929Phase 4
- Allogeneic Cytokine-induced Killer Immunotherapy for Relapse After Allogeneic Marrow Transplant for Haematological MalignanciesCompletedNCT00460694Phase 1/2
- Prophylactic Transfer of Leukemia-reactive T Cells After Allogeneic TransplantationCompletedNCT00460629Phase 1/2
- Gemtuzumab Ozogamicin Before Allogeneic Stem Cell TransplantationStatus unknownNCT00460447Phase 1/2
- Quality of Life of Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)CompletedNCT00459524
- GTI-2040 in Treating Patients With Relapsed, Refractory, or High-Risk Acute Leukemia, High-Grade Myelodysplastic Syndromes, or Refractory or Blastic Phase Chronic Myelogenous LeukemiaCompletedNCT00459212Phase 1
- Talotrexin in Treating Young Patients With Recurrent Solid Tumors or Leukemia That is Recurrent or Does Not Respond to TreatmentWithdrawnNCT00458744Phase 1
- Bevacizumab and Cediranib Maleate in Treating Patients With Metastatic or Unresectable Solid Tumor, Lymphoma, Intracranial Glioblastoma, Gliosarcoma or Anaplastic AstrocytomaCompletedNCT00458731Phase 1
- Treatment of B-Chronic Lymphocytic Leukemia (B-CLL) With Autologous CD40 Ligand and IL-2-Expressing Tumor CellsCompletedNCT00458679Phase 1
- Alemtuzumab in Treating Patients With B-Cell Chronic Lymphocytic Leukemia in Partial Remission or Complete RemissionCompletedNCT00458523Phase 2
- Feasibility of Haploidentical Hematopoietic Stem Cell Transplantation Using CAMPATH-1HCompletedNCT00458250Phase 1
- Safety Study of CAT-8015 Immunotoxin in Patients With CLL, PLL or SLL With Advance DiseaseStatus unknownNCT00457860Phase 1
- A Phase I Safety, PK and PD Study of KW-2478 in Patients With Multiple Myeloma, Chronic Lymphocytic Leukaemia or B-cell Non-Hodgkin's LymphomaCompletedNCT00457782Phase 1
- Combination Chemotherapy With or Without Gemtuzumab Ozogamicin or Tipifarnib in Treating Patients With Acute Myeloid Leukemia or High-Risk Myelodysplastic SyndromesCompletedNCT00454480Phase 2/3
- Vaccine Therapy and GM-CSF in Treating Patients With Acute Myeloid Leukemia in RemissionStatus unknownNCT00454168Phase 3
- A Study of Enzastaurin in Patients With LeukemiaCompletedNCT00452257Phase 1
- Gleevec/Low-Dose Ara-C Study for Elderly Patients With AML and Myelodysplastic SyndromesCompletedNCT00451997Phase 2
- Intermittent Liposomal Amphotericin B Primary ProphylaxisStatus unknownNCT00451711Phase 2
- Anti-CD19 and Anti-CD22 Immunotoxins in Treating Patients With Refractory or Relapsed B-Cell Acute Lymphoblastic LeukemiaCompletedNCT00450944Phase 1
- Autologous Stem Cell Transplants for Chronic Myelogenous LeukemiaWithdrawnNCT00446173Phase 2
- Registration of Children With CML and Treatment With ImatinibStatus unknownNCT00445822
- Reduced Intensity Stem Cell Transplantation for Chronic Lymphocytic Leukemia Followed by VaccinationCompletedNCT00442130Phase 1
- GIMEMA LAL 0496: High-dose Anthracycline in the Induction Regimen for the Treatment of Adult ALL.Status unknownNCT00439920Phase 2
- Sibling Donor Peripheral Stem Cell Transplant or Sibling Donor Bone Marrow Transplant in Treating Patients With Hematologic Cancers or Other DiseasesCompletedNCT00438958Phase 3
- Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic LeukemiaCompletedNCT00437060
- A Phase I/II Study to Assess the Safety and Tolerability of APO866 for the Treatment of Refractory B-CLLCompletedNCT00435084Phase 1/2
- A Phase II Study of MGCD0103 (MG-0103) in Patients With Refractory Chronic Lymphocytic LeukemiaCompletedNCT00431873Phase 2
- Liposomal Annamycin in Children and Young Adults With Refractory or Relapsed ALL or AMLTerminatedNCT00430443Phase 1
- Combination Chemotherapy Based on Risk of Relapse in Treating Young Patients With Acute Lymphoblastic LeukemiaCompletedNCT00430118Phase 3
- Natural History Study of Patients With Chronic Myelogenous LeukemiaCompletedNCT00429910
- Effect of Imatinib Mesylate and the Pharmacokinetics of Acetaminophen/Paracetamol in Patients With Newly Diagnosed, Previously Untreated Chronic Myeloid Leukemia in Chronic Phase (CML-CP)CompletedNCT00428909Phase 1
- Timed-Sequential Induction in CBF-AMLCompletedNCT00428558Phase 3
- Banking of Chronic Lymphocytic Leukemia Tumor Cells for Vaccine GenerationCompletedNCT00428233Phase 1
- Multimodal Intervention in Allogeneic Stem Cell TransplantationCompletedNCT00427115Phase 3
- GM-CSF Vaccinations After Allogeneic Blood Stem Cell Transplantation in Patients With Advanced Myeloid MalignanciesCompletedNCT00426205Not applicable
- Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal MetastasesCompletedNCT00424242Early Phase 1
- Umbilical Cord Blood Stem Cell Transplant in Treating Patients With Hematologic Cancer or Other DiseaseNo longer availableNCT00423826
- A Dose Escalation Study of Lenalidomide in Relapsed or Refractory B-cell Chronic Lymphocytic LeukemiaCompletedNCT00419250Phase 1
- Study of Forodesine Hydrochloride in Patients With Relapsed/Refractory Precursor T-Lymphoblastic Leukemia/Lymphoma Who Have Failed Two or More Prior Treatment RegimensTerminatedNCT00419081Phase 2
- Combination Chemotherapy With or Without G-CSF in Treating Patients With Relapsed Chronic Lymphocytic LeukemiaTerminatedNCT00416910Phase 3
- Safety, Efficacy and Pharmacokinetics of an Antifungal in Patients Undergoing ChemotherapyCompletedNCT00413439Phase 2/3
- Oral Nilotinib in Adults With Chronic Myeloid Leukemia (CML) in Blast Crisis Who Are Imatinib Resistant or IntolerantNo longer availableNCT00413270
- Pulses of Vincristine and Dexamethasone in BFM Protocols for Children With Acute Lymphoblastic LeukemiaCompletedNCT00411541Phase 4
- Gemcitabine Plus Busulfan, Melphalan and Hematopoietic Cell Transplant for Advanced Lymphoid MalignanciesCompletedNCT00410982Phase 1
- Alemtuzumab and Glucocorticoids in Treating Newly Diagnosed Acute Graft-Versus-Host Disease in Patients Who Have Undergone a Donor Stem Cell TransplantCompletedNCT00410657Phase 2
- Treatment of Newly Diagnosed Patients With Acute Promyelocytic Leukemia (PETHEMA LPA 2005)CompletedNCT00408278Phase 4
- Clinical Evaluation of Nelarabine (506U78)in Japanese Patients With Leukemia or LymphomaCompletedNCT00406757Phase 1
- A Phase II Study of MK0457 in Patients With T315I Mutant CML and Ph+All (0457-008)TerminatedNCT00405054Phase 2
- Ovarian Damage in Young Premenopausal Women Undergoing Chemotherapy for CancerWithdrawnNCT00402935
- Alloreactive NK Cells for Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)CompletedNCT00402558Phase 1
- Safety, Tolerability and Pharmacokinetics of CSL360 in the Treatment of Acute Myeloid LeukemiaCompletedNCT00401739Phase 1
- A Risk-Oriented Therapeutic Strategy for Adult Acute Myelogenous LeukemiaCompletedNCT00400673Phase 2
- AMD3100 With Busulfan, Fludarabine and Thymoglobulin for Allogeneic Stem Cell Transplant for AML and MDSWithdrawnNCT00396968Phase 1/2
- Autologous Cytokine-induced Killer Cell Adoptive Immunotherapy for Acute Myeloid Leukemia and Myelodysplastic SyndromeCompletedNCT00394381Phase 1/2
- Phase II Study of Perifosine in Patients With Refractory and Relapsed LeukemiaCompletedNCT00391560Phase 2
- Lumiliximab With Fludarabine, Cyclophosphamide, and Rituximab (FCR) Versus FCR Alone in Subjects With Relapsed Chronic Lymphocytic Leukemia (CLL)TerminatedNCT00391066Phase 2
- Nebulized Liposomal Amphotericin B Ambisome for Prophylaxis of Invasive Pulmonary AspergillosisCompletedNCT00391014Phase 2
- Glivec® (Imatinib Mesylate, STI571) in Monotherapy Versus Glivec®-Interferon Alpha in the Treatment of Chronic-Phase Chronic Myeloid LeukaemiaCompletedNCT00390897Phase 4
- Treatment of Acute Myeloblastic Leukemia in Younger PatientsCompletedNCT00390715
- Glivec in Ph Positive Lymphoblastic LeukemiaCompletedNCT00388895Phase 2
- ABT-888 in Patients With Refractory Solid Tumors or Hematologic CancerCompletedNCT00387608Phase 1
- Use and Tolerability of Imatinib Mesylate (Gleevec) in Leukemia PatientsCompletedNCT00386373Not applicable
- A Phase l/ll Study of AMN107 in Adult Patients With Glivec-intolerant CML or Relapsed-refractory Ph+ALLCompletedNCT00384228Phase 1/2
- Immunotherapy With NK Cell, Rituximab and Rhu-GMCSF in Non-Myeloablative Allogeneic Stem Cell TransplantationCompletedNCT00383994Phase 1
- Tipifarnib and Bortezomib in Treating Patients With Acute Leukemia or Chronic Myelogenous Leukemia in Blast PhaseCompletedNCT00383474Phase 1
- Phase I Using Velcade & Idarubicin in Elderly and Relapsed AMLCompletedNCT00382954Phase 1
- Safety and Pharmacology Study of Sapacitabine to Treat Advanced Leukemias or Myelodysplastic SyndromesCompletedNCT00380653Phase 1
- Acute Promyelocytic Leukemia 2006 (APL)Status unknownNCT00378365Phase 3
- Alvocidib in Treating Patients With B-Cell Chronic Lymphocytic Leukemia or Small Lymphocytic LymphomaTerminatedNCT00377104Phase 1
- Music in Reducing Anxiety and Pain in Adult Patients Undergoing Bone Marrow Biopsy for Hematologic Cancers or Other DiseasesCompletedNCT00376922Not applicable
- Umbilical Cord Blood T-Regulatory Cell Infusion Followed by Donor Umbilical Cord Blood Transplant in Treating Patients With High-Risk Leukemia or Other Hematologic DiseasesTerminatedNCT00376519Phase 1
- Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell TransplantCompletedNCT00376480Phase 1
- STI 571 (GLIVEC) in the Treatment of Adult Acute Lymphoblastic LeukemiaCompletedNCT00376467Phase 2
- MGCD0103 in Elderly Patients With Previously Untreated AML/High Risk MDS or Adults With Relapsed/Refractory DiseaseTerminatedNCT00374296Phase 2
- Lower But More Frequent Dose Rituximab to Treat Chronic Lymphocytic LeukemiaCompletedNCT00366418Phase 1
- Combination Chemotherapy and Total-Body Irradiation Before Donor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic Cancer, Metastatic Breast Cancer, or Kidney CancerCompletedNCT00365287Phase 1/2
- A Randomized Study of Post-Remission Therapy in Elderly Patients With Acute Myelogenous Leukemia.TerminatedNCT00363025Phase 3